Closed Research Studies:
SPRINT - This is research opportunity for people who are concerned about their blood pressure. This study is being conducted at The Ohio State University Medical Center to provide you with better blood pressure control through exams, testing and medication.
REWIND- Taking care of you heart is important when you have type 2 diabetes. That’s why we’re conducting REWIND, a clinical research study looking at an investigational drug given once- weekly to study the effects on heart disease and stroke in type 2 diabetes. If you have type 2 diabetes, are at least 50 years old and are (or think you may be) at risk of these events, please contact the study team to learn more about taking part.
EMORY: This is an inpatient Type 2 diabetes study. We are comparing Glargine and Sitagliptin, to a Basal Bolus regimen. The patient will be randomized to one of the two groups. The patient must be in the hospital at least 24 hours post consenting. There is an inpatient portion, as well as an outpatient portion. The study lasts about 6 months, including the inpatient portion, and 3 follow up visits. At each of these follow up visits (held at CarePoint East) they will be reimbursed 75$. Their diabetes will be managed by Dr. Dungan.